To include your compound in the COVID-19 Resource Center, submit it here.
Blue Ash granted Forest exclusive, worldwide rights to antiarrhythmic candidate azimilide. Last year, Blue Ash
Sign in to your BioCentury account to access your content.
Get a two-week free trial subscription to BioCentury